Skip to main content

Post-IPO Equity Therapeutics Companies

Explore 5 therapeutics startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
5
Total Funding
$251.0M
Avg Funding
$50.2M
Cities
5

Export 5 Post-IPO Equity Therapeutics Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
San Diego, United States
$6.0M
raised

Calidi Biotherapeutics is a clinical-stage biotechnology company developing immunotherapies for cancer.

Mar 2026
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Chicago, United States
$30.0M
raised

MAIA Biotechnology is a clinical-stage biopharmaceutical company developing cancer therapies that target telomeres through immunotherapy.

Mar 2026
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Sioux Falls, United States
$85.0M
raised

SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.

Mar 2026
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Cambridge, United States
$100.0M
raised

Elicio Therapeutics is a pharmaceutical research company that develops an immuno-tumor vaccine to treat cancer.

Mar 2026
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Miami, United States
$30.0M
raised

Longeveron is a biotechnology company that focuses on developing cellular therapies for chronic aging-related and life-threatening diseases.

Mar 2026
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Ready to Connect with Post-IPO Equity Therapeutics Startups?

Get verified founder emails, funding details, and company data for 5 post-ipo equity therapeutics companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked